Background: In US men, prostate cancer is the most common noncutaneous cancer and the
second leading cause of cancer death. Screening for prostate cancer is controversial …

Abstract Each year the American Cancer Society publishes a summary of existing
recommendations for early cancer detection, including updates, and/or emerging issues that …

Objective: To determine whether the more intensive screening and treatment for prostate
cancer in the Seattle-Puget Sound area in 1987-90 led to lower mortality from prostate …

The large majority of human cancer diagnosed each year may be avoidable, but avoidable
causes of many common cancers have not yet been clearly identified. A prerequisite of …

Complexed PSA (cPSA) has been shown to improve specificity in the detection of prostate
cancer over that of total PSA (tPSA) testing in men with tPSA values greater than the cutoff …

André N. Vis based screening for prostate cancer resulted in a reduction in prostate cancer
mortality of up to 70% in those subjected to screening compared with those who were not …

Preventative medicine is well established in different areas, but it is still a relatively new
concept in urology. Nutrition and environmental factors are suspected to play a major role in …

The arguments for and against screening for prostatic cancer are frequently discussed
(Albertsen PC. Screening for prostate cancer is neither appropriate nor cost‐effective. Urol …

Prostate-specific antigen (PSA) testing advances the diagnosis of prostate cancer, shifting
the stage at diagnosis towards localised disease. However, the widespread application of …

Die familiäre Disposition zählt zu den wichtigsten Risikofaktoren für das Prostatakarzinom
(PCA). In einer prospektiven Studie wurde die PCA-Detektionsrate bei anamnestisch …